D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 50 Citations 9,834 225 World Ranking 13068 National Ranking 5550

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Internal medicine

His primary areas of investigation include Pharmacology, Hepatocyte, Biochemistry, Cell culture and In vivo. His research integrates issues of Cytochrome P450 and Enzyme inducer in his study of Pharmacology. Albert P. Li has researched Hepatocyte in several fields, including Membrane transport, Perfusion, Andrology, Liver cytology and Metabolism.

His study explores the link between Biochemistry and topics such as Molecular biology that cross with problems in Phosphoribosyl transferase and Chinese hamster ovary cell. His Cell culture study combines topics in areas such as Cancer research, In vitro toxicology, Cancer cell, Endoplasmic reticulum and Cuboidal Cell. His work in In vivo addresses subjects such as In vitro, which are connected to disciplines such as Clinical trial.

His most cited work include:

  • Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies (590 citations)
  • Screening for human ADME/Tox drug properties in drug discovery (341 citations)
  • Substrates of human hepatic cytochrome P450 3A4 (321 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Pharmacology, Biochemistry, Cell culture, In vitro and Drug metabolism. His Pharmacology research is multidisciplinary, relying on both Toxicity and Cytochrome P450. The Cytochrome P450 study combines topics in areas such as Isozyme and Enzyme inducer.

The concepts of his Cell culture study are interwoven with issues in Cell and Cell biology. In his work, Computational biology and Sulfation is strongly intertwined with In vivo, which is a subfield of In vitro. His study in Drug metabolism is interdisciplinary in nature, drawing from both Intestinal mucosa, Cryopreservation and CYP2A6.

He most often published in these fields:

  • Pharmacology (35.65%)
  • Biochemistry (31.30%)
  • Cell culture (21.30%)

What were the highlights of his more recent work (between 2015-2021)?

  • Pharmacology (35.65%)
  • Drug metabolism (16.52%)
  • Biochemistry (31.30%)

In recent papers he was focusing on the following fields of study:

Albert P. Li mainly focuses on Pharmacology, Drug metabolism, Biochemistry, In vitro and Cryopreservation. His work carried out in the field of Pharmacology brings together such families of science as CYP3A, Drug metabolizing enzymes and Metabolism. His Drug metabolism research integrates issues from CYP3A4, Enterocyte, In vitro system and Intestinal mucosa.

His research in the fields of Glucuronidation, Microsome, CYP1A2 and Detoxification overlaps with other disciplines such as Throughput. His studies in In vitro integrate themes in fields like Transporter, Chromatography, Bioassay, Biotransformation and In vivo. His In vivo study incorporates themes from Cell culture, Pharmacokinetics, Free fraction and Hepatocyte.

Between 2015 and 2021, his most popular works were:

  • Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations (43 citations)
  • Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four Donors. (28 citations)
  • Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles (26 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Internal medicine

His primary areas of study are Pharmacology, Biochemistry, In vivo, In vitro and CYP3A4. A large part of his Pharmacology studies is devoted to Drug. His biological study spans a wide range of topics, including Ileum, Jejunum, Cytochrome P450 and Hepatocyte.

Albert P. Li has researched Hepatocyte in several fields, including Unfolded protein response, Endoplasmic reticulum and Salubrinal. Pharmacokinetics, Metabolism and Metabolite is closely connected to Transporter in his research, which is encompassed under the umbrella topic of In vitro. His CYP3A4 study integrates concerns from other disciplines, such as Intestinal mucosa and Drug metabolism.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

Nicola J. Hewitt;Maria Jose Gomez Lechon;J. Brian Houston;David Hallifax.
Drug Metabolism Reviews (2007)

955 Citations

Screening for human ADME/Tox drug properties in drug discovery

Albert P Li.
Drug Discovery Today (2001)

602 Citations

Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.

Albert P Li;Chuang Lu;Julie A Brent;Chuong Pham.
Chemico-Biological Interactions (1999)

433 Citations

Substrates of human hepatic cytochrome P450 3A4

Albert P. Li;Donald L. Kaminski;Asenath Rasmussen.
Toxicology (1995)

421 Citations

Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A

Yoshihisa Shitara;Tomoo Itoh;Hitoshi Sato;Albert P. Li.
Journal of Pharmacology and Experimental Therapeutics (2003)

406 Citations

Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog.

Chuang Lu;Albert P. Li.
Chemico-Biological Interactions (2001)

262 Citations

Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes.

Judy Easterbrook;Chuang Lu;Yumiko Sakai;Albert P. Li.
Drug Metabolism and Disposition (2001)

246 Citations

Optimization of cryopreservation procedures for rat and human hepatocytes.

L. J. Loretz;A. P. Li;M. W. Flye;A. G. E. Wilson.
Xenobiotica (1989)

239 Citations

A review of the common properties of drugs with idiosyncratic hepatotoxicity and the “multiple determinant hypothesis” for the manifestation of idiosyncratic drug toxicity

Albert P Li.
Chemico-Biological Interactions (2002)

232 Citations

Human hepatocytes: isolation, cryopreservation and applications in drug development

Albert P. Li.
Chemico-Biological Interactions (2007)

231 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Albert P. Li

Jan G. Hengstler

Jan G. Hengstler

TU Dortmund University

Publications: 66

Yuichi Sugiyama

Yuichi Sugiyama

University of Tokyo

Publications: 51

Mikko Niemi

Mikko Niemi

University of Helsinki

Publications: 24

André Guillouzo

André Guillouzo

University of Rennes

Publications: 24

Martin L. Yarmush

Martin L. Yarmush

Rutgers, The State University of New Jersey

Publications: 22

Olavi Pelkonen

Olavi Pelkonen

University of Oulu

Publications: 22

Vera Rogiers

Vera Rogiers

Vrije Universiteit Brussel

Publications: 21

Pertti J. Neuvonen

Pertti J. Neuvonen

University of Helsinki

Publications: 20

José V. Castell

José V. Castell

University of Valencia

Publications: 19

Leslie Z. Benet

Leslie Z. Benet

University of California, San Francisco

Publications: 19

Tsuyoshi Yokoi

Tsuyoshi Yokoi

Nagoya University

Publications: 18

Li Di

Li Di

Pfizer (United States)

Publications: 18

Tommy B. Andersson

Tommy B. Andersson

AstraZeneca (United Kingdom)

Publications: 17

Robert H. Heflich

Robert H. Heflich

United States Food and Drug Administration

Publications: 17

Nico P. E. Vermeulen

Nico P. E. Vermeulen

Vrije Universiteit Amsterdam

Publications: 17

Hanry Yu

Hanry Yu

National University of Singapore

Publications: 17

Trending Scientists

J. Ross Macdonald

J. Ross Macdonald

University of North Carolina at Chapel Hill

David Andre

David Andre

X, the moonshot factory

José Manuel Andreu

José Manuel Andreu

Spanish National Research Council

Derek O. Northwood

Derek O. Northwood

University of Windsor

Wadood Y. Hamad

Wadood Y. Hamad

FPInnovations

Zhijun Ning

Zhijun Ning

ShanghaiTech University

Bart A. Nolet

Bart A. Nolet

University of Amsterdam

Stefan Schulte-Merker

Stefan Schulte-Merker

University of Münster

Tom Kadesch

Tom Kadesch

University of Pennsylvania

Albert Tietema

Albert Tietema

University of Amsterdam

Frédéric Francis

Frédéric Francis

Gembloux Agro-Bio Tech

Robert W. Collier

Robert W. Collier

Oregon State University

Rebecca Elliott

Rebecca Elliott

University of Manchester

Bram P. Buunk

Bram P. Buunk

University of Groningen

Esther Thelen

Esther Thelen

Indiana University

John R. Nesselroade

John R. Nesselroade

University of Virginia

Something went wrong. Please try again later.